Cite
HARVARD Citation
van Vollenhoven, R. et al. (2020). Maintenance of Efficacy and Safety of Ustekinumab Through One Year in a Phase II Multicenter, Prospective, Randomized, Double‐Blind, Placebo‐Controlled Crossover Trial of Patients With Active Systemic Lupus Erythematosus. Arthritis & rheumatology. 72 (5), pp. 761-768. [Online].